Fortrea Holdings (MEX:FTRE1) Research & Development: MXN0 Mil (TTM As of Mar. 2026)


MEX:FTRE1 Fortrea Holdings Inc MEX:FTRE1
66 GF Score
Price MXN435.30
GF Value MXN450.34
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Research & Development?

Fortrea Holdings MEX:FTRE1 66 Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:FTRE1 with a GF Score™ of 66/100 and a GF Value™ of MXN450.34. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fortrea Holdings's Research & Development for the three months ended in Mar. 2026 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN0 Mil.

Fortrea Holdings  (MEX:FTRE1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fortrea Holdings Research & Development Related Terms

Fortrea Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Research & Development Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:FTRE1
66GF Score
Fortrea Holdings Inc MEX:FTRE1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN0 Mil mean?
Fortrea Holdings (MEX:FTRE1) has a Research & Development of MXN0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Fortrea Holdings and its competitors.
Is Fortrea Holdings' Research & Development too high?
Fortrea Holdings' current Research & Development is MXN0 Mil. Overall, Fortrea Holdings has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Research & Development compare to MAZE and KALV?
Fortrea Holdings' Research & Development of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Research & Development is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Fortrea Holdings (MEX:FTRE1) has a current Research & Development of MXN0 Mil. The stock's GF Value™ is MXN450.34, compared to a current price of MXN435.30 — trading 3.3% below its estimated fair value. The current Research & Development is MXN0 Mil. Fortrea Holdings' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fortrea Holdings (MEX:FTRE1), the current Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (MEX:FTRE1) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of MXN435.30 is trading 3.3% below its estimated GF Value™ of MXN450.34.

Key valuation signals for MEX:FTRE1:

  • Research & Development: MXN0 Mil
  • GF Value™: MXN450.34 vs. price of MXN435.30 (3.3% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the MEX:FTRE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges FTRE:USAK67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
66GF Score

Get the complete analysis for MEX:FTRE1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN435.30
Price
MXN450.34
GF Value